DK1353923T3 - Forbedret fremgangsmåde til syntese af carbapenem - Google Patents

Forbedret fremgangsmåde til syntese af carbapenem

Info

Publication number
DK1353923T3
DK1353923T3 DK02701042T DK02701042T DK1353923T3 DK 1353923 T3 DK1353923 T3 DK 1353923T3 DK 02701042 T DK02701042 T DK 02701042T DK 02701042 T DK02701042 T DK 02701042T DK 1353923 T3 DK1353923 T3 DK 1353923T3
Authority
DK
Denmark
Prior art keywords
carbapenem
synthesis
improved method
improved
Prior art date
Application number
DK02701042T
Other languages
English (en)
Inventor
John M Williams
Renato Skerlj
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK1353923T3 publication Critical patent/DK1353923T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02701042T 2001-01-16 2002-01-11 Forbedret fremgangsmåde til syntese af carbapenem DK1353923T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26193301P 2001-01-16 2001-01-16
US29344001P 2001-05-24 2001-05-24
PCT/US2002/000821 WO2002057266A1 (en) 2001-01-16 2002-01-11 Improved process for carbapenem synthesis

Publications (1)

Publication Number Publication Date
DK1353923T3 true DK1353923T3 (da) 2005-01-31

Family

ID=26948925

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02701042T DK1353923T3 (da) 2001-01-16 2002-01-11 Forbedret fremgangsmåde til syntese af carbapenem

Country Status (29)

Country Link
US (1) US7071330B2 (da)
EP (1) EP1353923B1 (da)
JP (1) JP4098626B2 (da)
KR (1) KR100827562B1 (da)
CN (1) CN1249065C (da)
AR (1) AR035728A1 (da)
AT (1) ATE278691T1 (da)
AU (1) AU2002234240B2 (da)
BR (1) BR0206372A (da)
CA (1) CA2433874C (da)
CZ (1) CZ301440B6 (da)
DE (1) DE60201498T2 (da)
DK (1) DK1353923T3 (da)
EA (1) EA006098B1 (da)
EG (1) EG23993A (da)
ES (1) ES2227423T3 (da)
HR (1) HRP20030566B1 (da)
HU (1) HUP0302764A3 (da)
IL (2) IL156507A0 (da)
MX (1) MXPA03006322A (da)
NZ (1) NZ527191A (da)
PL (1) PL362912A1 (da)
PT (1) PT1353923E (da)
RS (1) RS50494B (da)
SI (1) SI1353923T1 (da)
SK (1) SK287350B6 (da)
TW (1) TWI318627B (da)
UA (1) UA74870C2 (da)
WO (1) WO2002057266A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016312A1 (fr) * 2001-08-13 2003-02-27 Eisai Co., Ltd. Procede de preparation d'antibiotiques a base de carbapenem
ES2368997T3 (es) * 2001-09-26 2011-11-24 Merck Sharp & Dohme Corp. Procedimiento de fabricación de compuestos de carbapenem.
AU2002331885B2 (en) 2001-09-26 2007-07-26 Merck & Co., Inc. Crystalline forms of ertapenem sodium
JP2005509037A (ja) * 2001-11-16 2005-04-07 ランバクシー ラボラトリーズ リミテッド 結晶イミペネム製造方法
EP1582526A4 (en) * 2002-11-13 2008-08-06 Kaneka Corp NOVEL INTERMEDIATE FOR CARBAPENEM COMPOUND FOR ORAL ADMINISTRATION AND METHOD OF PRODUCING THE SAME
DE102005025899A1 (de) * 2005-06-06 2006-12-07 Basf Ag Verfahren zur Aufbereitung eines Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisches
AU2006290416B2 (en) * 2005-09-15 2012-04-12 Orchid Chemicals And Pharmaceuticals Limited An improved process for the preparation of beta-lactam antibiotic
US20100240886A1 (en) * 2006-03-28 2010-09-23 Kaneka Corporation Process for producing carbapenem compound
WO2008062279A2 (en) * 2006-11-20 2008-05-29 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of carbapenem antibiotic
CN101357920B (zh) * 2007-06-22 2011-01-12 山东轩竹医药科技有限公司 含有巯基吡咯烷甲酰胺基三嗪的培南化合物
CN101367807B (zh) * 2007-06-28 2011-01-12 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基吡啶取代的培南衍生物
CN101875665B (zh) 2009-04-30 2013-02-06 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南中间体、含其的组合物及其制备方法
CN102918041A (zh) * 2010-05-21 2013-02-06 山东轩竹医药科技有限公司 碳青霉烯衍生物或其水合物的晶型及其制备方法与用途
US8822445B2 (en) 2010-06-03 2014-09-02 Xuanzhu Pharma Co., Ltd. Crystalline form of carbapenem derivative or its hydrates and preparation methods and uses thereof
WO2012038979A2 (en) * 2010-09-24 2012-03-29 Sequent Anti Biotics Private Limited A process for preparation of ertapenem
CN102558182B (zh) 2010-12-31 2015-02-11 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南钠晶型及其制备方法
WO2013121279A2 (en) * 2012-02-14 2013-08-22 Aurobindo Pharma Limited Process to prepare ertapenem
WO2014097221A1 (en) * 2012-12-21 2014-06-26 Ranbaxy Laboratories Limited Process for the purification of biapenem
ES2731242T3 (es) * 2014-03-27 2019-11-14 Johnson Matthey Plc Procedimiento de preparación de un antibiótico carbapenem

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE794554A (fr) * 1972-01-31 1973-07-26 Lilly Co Eli Nouveaux derives de penicilline et de cephalusporine
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
US3897424A (en) * 1973-07-23 1975-07-29 Lilly Co Eli Process for 7-{62 -amino-7-{60 -methoxy-cephalosporanic acid esters and related compounds
AR207327A1 (es) * 1974-02-06 1976-09-30 Lilly Co Eli Un procedimiento para preparar acidos 3-cefem 3-sulfonatos y sus esteres
US4001226A (en) * 1974-12-04 1977-01-04 Eli Lilly And Company 3-(substituted)carbonylamino cephem derivatives
US3992377A (en) * 1974-12-13 1976-11-16 Eli Lilly And Company 3-Thio-substituted cephalosporin antibiotics
US3985746A (en) * 1975-03-25 1976-10-12 E. R. Squibb & Sons, Inc. 7-(α-Cyanomethylthio)acetamido-3-cephem carboxylates
US4217453A (en) * 1978-07-24 1980-08-12 Merck & Co., Inc. 6-Amido-3-substituted-amino-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid
US4656263A (en) * 1979-03-05 1987-04-07 Pfizer Inc. 6-β-substituted penicillanic acid compound free of the 6-α-epimer
US4299954A (en) * 1979-11-05 1981-11-10 Eli Lilly And Company Cephalosporin vinyl halides
US4414155A (en) 1980-01-14 1983-11-08 Merck & Co., Inc. Synthesis of thienamycin via esters of (3SR, 4RS)-3-[(SR)-1-hydroxyethyl]-β,2-dioxo-4-azetidinebutanoic acid
US4269772A (en) 1980-01-14 1981-05-26 Merck & Co., Inc. Synthesis of thienamycin via trans-3-carboxymethylene-4-carboxy-5-methyl-Δ2 -isoxazoline
US4369187A (en) * 1980-02-06 1983-01-18 Merck & Co., Inc. 3-Substituted-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid
US4383946A (en) 1980-03-27 1983-05-17 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
US4501741A (en) * 1983-04-12 1985-02-26 Eli Lilly And Company Cephalosporin antibiotics
US4783453A (en) * 1985-06-10 1988-11-08 Merck & Co., Inc. 2-aza-substituted 1-carbadethiapen-2-em-3-carboxylic acids
JPS6475488A (en) * 1987-09-17 1989-03-22 Sumitomo Pharma Production of beta-lactam compound
US5034384A (en) 1990-08-01 1991-07-23 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem antibacterial agents
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
UA62920C2 (en) 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
HRP970281B1 (en) 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
US6180783B1 (en) 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
US6063931A (en) 1997-07-09 2000-05-16 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
US5872250A (en) 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
ES2260900T3 (es) * 1998-03-02 2006-11-01 MERCK & CO., INC. Procedimiento para sintetizar antibioticos de carbapenem.

Also Published As

Publication number Publication date
ES2227423T3 (es) 2005-04-01
EA200300804A1 (ru) 2003-12-25
EA006098B1 (ru) 2005-08-25
HUP0302764A2 (hu) 2003-11-28
EP1353923A1 (en) 2003-10-22
YU55003A (sh) 2006-05-25
SI1353923T1 (en) 2005-02-28
CA2433874C (en) 2009-08-11
CN1249065C (zh) 2006-04-05
DE60201498T2 (de) 2005-11-17
ATE278691T1 (de) 2004-10-15
SK8972003A3 (en) 2003-10-07
AU2002234240B2 (en) 2006-04-27
CZ20031911A3 (cs) 2003-10-15
AR035728A1 (es) 2004-07-07
DE60201498D1 (de) 2004-11-11
IL156507A (en) 2010-06-30
NZ527191A (en) 2004-04-30
JP2004518672A (ja) 2004-06-24
US7071330B2 (en) 2006-07-04
HUP0302764A3 (en) 2005-11-28
PT1353923E (pt) 2005-01-31
PL362912A1 (en) 2004-11-02
RS50494B (sr) 2010-03-02
MXPA03006322A (es) 2003-10-06
KR100827562B1 (ko) 2008-05-07
TWI318627B (en) 2009-12-21
CZ301440B6 (cs) 2010-03-03
IL156507A0 (en) 2004-01-04
HRP20030566B1 (en) 2011-08-31
WO2002057266A1 (en) 2002-07-25
HRP20030566A2 (en) 2005-06-30
CA2433874A1 (en) 2002-07-25
US20040063931A1 (en) 2004-04-01
KR20040007438A (ko) 2004-01-24
CN1486318A (zh) 2004-03-31
JP4098626B2 (ja) 2008-06-11
EP1353923B1 (en) 2004-10-06
BR0206372A (pt) 2003-12-23
EG23993A (en) 2008-03-10
UA74870C2 (en) 2006-02-15
SK287350B6 (sk) 2010-08-09

Similar Documents

Publication Publication Date Title
DK1438306T3 (da) Derivater af UK-2A
DK1353923T3 (da) Forbedret fremgangsmåde til syntese af carbapenem
DK1312406T3 (da) Fremgangsmåde til rensning af syntesegas
DK1575416T3 (da) Fremgangsmåder til diagnosticering af præeklampsi
DK1432319T3 (da) Fremgangsmåde til fremstilling af hundefoder
DK1840125T3 (da) Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DK1414492T3 (da) Fremgangsmåde til behandling af multipel myeloma
DK1373255T3 (da) Fremgangsmåde til fremstilling af imidazolforbindelser
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
IS7069A (is) Aðferð til að framleiða zaleplon
DK1294659T3 (da) Fremgangsmåde til isolering af katamin
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
FI20012446A0 (fi) Menetelmä kartongin jälkikäsittelemiseksi
IS6884A (is) Aðferðir við að nýta líffræðilegan fjölbreytileika
DK1400522T3 (da) Forbindelser til behandling af impotens
DK1395587T3 (da) Fremgangsmåde til fremstilling af imipenem
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DE60226093D1 (de) Urmedium-Reinigungsmethode
DK1472412T3 (da) Byggesæt af brosten
DK1670773T3 (da) Fremgangsmåde til fremstilling af benzoxazol-sulfonamidforbindelser og mellemprodukter deraf
DK1373245T3 (da) Mellemprodukter til fremstilling af spinosyner
FI20011252A (fi) Rakennusmenetelmä
IS6928A (is) Aðferðir til að framleiða mirtasapínmilliefni
DK1229109T3 (da) Fremgangsmåde til fremstilling af glucose-1-phosphat